VINCOV-19
- Hyderabad
Hyderabad: UoH, CCMB’s COVID-19 antidote completes Phase 2 clinical trials
Hyderabad: The University of Hyderabad (UoH) and the Centre for Cellular and Molecular Biology (CCMB) in collaboration with VINCOV-19, developed the first antidote against COVID-19 and have successfully completed the Phase 2…